𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor

✍ Scribed by Seung-Woo Cho; Joung Eun Lim; Hun Su Chu; Hye-Jin Hyun; Cha Yong Choi; Ki-Chul Hwang; Kyung Jong Yoo; Dong-Ik Kim; Byung-Soo Kim


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
959 KB
Volume
76A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Successful reconstruction of large‐diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small‐diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony‐stimulating factor (G‐CSF) can enhance in vivo endothelialization of tissue‐engineered vascular grafts, which could be used to improve patency of small‐diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow–derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow–derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell‐seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G‐CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G‐CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G‐CSF–treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G‐CSF–treated grafts compared to the control grafts. This study suggests that G‐CSF administration could be applied to improve patency of small‐diameter tissue‐engineered vascular grafts. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006


📜 SIMILAR VOLUMES


Enhancement of plasminogen activator act
✍ Soichi Kojima; Hirohiko Tadenuma; Yuji Inada; Yuji Saito 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

A hitherto unknown function of granulocyte colony-stimulating factor (G-CSF) was found using cultured endothelial cells. G-CSF stimulated activity of plasminogen activator (PA) in both extracellular and intracellular milieus of endothelial cells obtained from bovine carotid and aortic artery. This e

Recombinant human granulocyte-colony sti
✍ Hal E. Broxmeyer; Douglas E. Williams; Scott Cooper; Giao Hangoc; Peter Ralph 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Combinations of low dosages of purified recombinant human (rh) macrophagecolony stimulating factor (M-CSF; also termed CSF-1) and rh granulocyte-colony stimulating factor (G-CSF) were compared alone and in combination for their influence on the cycling rates and numbers of bone marrow and splenic gr

Vascular endothelial growth factor media
✍ Bence Sipos; Dirk Weber; Hendrik Ungefroren; Holger Kalthoff; Andre Zühlsdorff; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 660 KB

## Abstract Angiogenesis in pancreatic ductal adenocarcinomas depends on the presence of angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) and is thought to be stimulated by hypoxia. We tested the angiogenic potential of 9 cell lines of p